stock
Enveric Biosciences Inc
NASDAQ | ENVB
10.33
USD
+$0.00
(+0.00%
)At Close (As of Dec 10, 2025)
$2.83M
Market Cap
-
P/E Ratio
-119.64
EPS
$96.30
52 Week High
$4.88
52 Week Low
HEALTHCARE
Sector
ENVB Chart
Recent Chart
Price Action
ENVB Technicals
ENVB Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | -$337K |
| Total Revenue | $0 |
| Cost Of Revenue | $337K |
| Costof Goods And Services Sold | $337K |
| Operating Income | -$9.6M |
| Selling General And Administrative | $6.5M |
| Research And Development | $2.8M |
| Operating Expenses | $9.3M |
| Investment Income Net | - |
| Net Interest Income | $219 |
| Interest Income | $219 |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $337K |
| Income Before Tax | -$9.6M |
| Income Tax Expense | $8.9K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$9.6M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$9.6M |
| Ebitda | -$9.2M |
| Net Income | -$9.6M |
Revenue & Profitability
ENVB Financials
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$7.7M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $337K |
| Capital Expenditures | $0 |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | $7.7M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | $1.1M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$9.6M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | -$337K |
| Total Revenue | $0 |
| Cost Of Revenue | $337K |
| Costof Goods And Services Sold | $337K |
| Operating Income | -$9.6M |
| Selling General And Administrative | $6.5M |
| Research And Development | $2.8M |
| Operating Expenses | $9.3M |
| Investment Income Net | - |
| Net Interest Income | $219 |
| Interest Income | $219 |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $337K |
| Income Before Tax | -$9.6M |
| Income Tax Expense | $8.9K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$9.6M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$9.6M |
| Ebitda | -$9.2M |
| Net Income | -$9.6M |
ENVB Profile
Enveric Biosciences Inc Profile
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Enveric Biosciences Inc. is an innovative pharmaceutical company headquartered in Florida, specializing in the development of cannabinoid-based therapeutics aimed at improving treatment outcomes for cancer patients. Utilizing its extensive expertise in cannabinoid research, Enveric is committed to creating groundbreaking drug candidates that address significant unmet medical needs in oncology, thereby enhancing the quality of life for those affected by cancer. With a robust focus on clinical development, the company is well-positioned to leverage the growing intersection of cannabinoid science and cancer care, striving to redefine therapeutic approaches in a rapidly evolving market.
LPTX +368.57%
$2.05
MNTS +23.16%
$0.94
PAVS -14.12%
$0.03
NVDA -0.53%
$183.98
ATPC -95.04%
$0.06
IRBT +48.44%
$5.24
VHAI -25.00%
$0.00
WOK -96.82%
$0.17
ONDS -9.80%
$8.32
WBD +4.54%
$29.54
ASST -1.96%
$1.02
AXDX -61.36%
$0.03
IBIO +26.57%
$2.81
INTC +0.96%
$40.89
NFLX -4.28%
$92.57
SOFI +0.80%
$27.04
TSLA +1.77%
$453.09
AAL +0.73%
$15.14
PLUG -0.78%
$2.19
ADAP -15.14%
$0.05
PLTR +3.98%
$189.09
ABEV -0.80%
$2.45
BBGI +356.79%
$18.50
SOND -23.45%
$0.12
DNN -2.91%
$2.66
RMBL +60.50%
$3.21
RIVN +1.33%
$17.94
RIG -3.25%
$4.30
LNW -3.71%
$86.22
HPE +2.01%
$25.27
ADD -25.47%
$0.05
BYND +3.13%
$1.29
SRM +53.27%
$10.30
RGTI -5.97%
$26.53
ENVB +69.93%
$10.06
MSFT -2.73%
$478.56
BMNU
+12.04%
$12.00
AAPL +0.57%
$278.78
UBER -6.28%
$83.47
CFLT +0.40%
$30.02
MTSR -0.35%
$70.50
AMZN +1.66%
$231.71
ORCL +0.86%
$223.44
POM
-90.77%
$0.50
PLTD -3.82%
$6.28
CLSK -1.01%
$14.69
BTBT -0.21%
$2.36
CGTL +47.40%
$0.97
BBD +0.63%
$3.34
SIDU +42.60%
$1.13
BLNK -5.90%
$0.94
KITT +3.77%
$1.10
CIFR -3.22%
$18.93
AFMD -34.94%
$0.18
GRAB +1.26%
$5.21
MARA -0.48%
$12.19
CRWV
-1.92%
$88.91
RKLB +5.80%
$56.53
SMR -4.64%
$20.33
IREN -4.21%
$44.86
GOOGL +0.92%
$320.01
BITF -2.47%
$2.93
T -0.87%
$24.29
TE +11.79%
$6.73
BTE +0.31%
$3.09
GOOG +1.02%
$321.00
DVLT -6.05%
$1.47
KEY +2.70%
$20.52
RDW +2.60%
$7.48
GRYP -10.38%
$1.38
F +0.22%
$13.11
ADVB +2.75%
$0.37
VZ -0.60%
$39.89
MODV -25.22%
$0.43
AMCR +1.23%
$8.21
WFC +1.91%
$90.59
BMNR
0.00%
$39.21
CHR -2.67%
$0.04
BNKK
-21.08%
$0.11
ACHR -0.94%
$8.54
QBTS -2.48%
$27.62
WULF +3.33%
$16.11
SOUN -1.04%
$12.18
MIGI +45.65%
$6.70
JBLU +1.41%
$5.03
BDRX +86.97%
$7.61
KVUE +0.99%
$17.18
MRVL +3.32%
$91.85
TWOH
+16.66%
$0.00
WRBY +20.70%
$28.02
CHWY -1.23%
$34.41
YGMZ -19.73%
$0.05
CGC +1.78%
$1.15
LYFT -7.90%
$20.05
IONQ -5.05%
$51.69
SMCI -0.55%
$34.82
AMD -0.41%
$220.70
HBAN +1.20%
$17.19
SHOT -74.37%
$0.39
RR +1.38%
$4.40
LPTX +368.57%
$2.05
MNTS +23.16%
$0.94
PAVS -14.12%
$0.03
NVDA -0.53%
$183.98
ATPC -95.04%
$0.06
IRBT +48.44%
$5.24
VHAI -25.00%
$0.00
WOK -96.82%
$0.17
ONDS -9.80%
$8.32
WBD +4.54%
$29.54
ASST -1.96%
$1.02
AXDX -61.36%
$0.03
IBIO +26.57%
$2.81
INTC +0.96%
$40.89
NFLX -4.28%
$92.57
SOFI +0.80%
$27.04
TSLA +1.77%
$453.09
AAL +0.73%
$15.14
PLUG -0.78%
$2.19
ADAP -15.14%
$0.05
PLTR +3.98%
$189.09
ABEV -0.80%
$2.45
BBGI +356.79%
$18.50
SOND -23.45%
$0.12
DNN -2.91%
$2.66
RMBL +60.50%
$3.21
RIVN +1.33%
$17.94
RIG -3.25%
$4.30
LNW -3.71%
$86.22
HPE +2.01%
$25.27
ADD -25.47%
$0.05
BYND +3.13%
$1.29
SRM +53.27%
$10.30
RGTI -5.97%
$26.53
ENVB +69.93%
$10.06
MSFT -2.73%
$478.56
BMNU
+12.04%
$12.00
AAPL +0.57%
$278.78
UBER -6.28%
$83.47
CFLT +0.40%
$30.02
MTSR -0.35%
$70.50
AMZN +1.66%
$231.71
ORCL +0.86%
$223.44
POM
-90.77%
$0.50
PLTD -3.82%
$6.28
CLSK -1.01%
$14.69
BTBT -0.21%
$2.36
CGTL +47.40%
$0.97
BBD +0.63%
$3.34
SIDU +42.60%
$1.13
BLNK -5.90%
$0.94
KITT +3.77%
$1.10
CIFR -3.22%
$18.93
AFMD -34.94%
$0.18
GRAB +1.26%
$5.21
MARA -0.48%
$12.19
CRWV
-1.92%
$88.91
RKLB +5.80%
$56.53
SMR -4.64%
$20.33
IREN -4.21%
$44.86
GOOGL +0.92%
$320.01
BITF -2.47%
$2.93
T -0.87%
$24.29
TE +11.79%
$6.73
BTE +0.31%
$3.09
GOOG +1.02%
$321.00
DVLT -6.05%
$1.47
KEY +2.70%
$20.52
RDW +2.60%
$7.48
GRYP -10.38%
$1.38
F +0.22%
$13.11
ADVB +2.75%
$0.37
VZ -0.60%
$39.89
MODV -25.22%
$0.43
AMCR +1.23%
$8.21
WFC +1.91%
$90.59
BMNR
0.00%
$39.21
CHR -2.67%
$0.04
BNKK
-21.08%
$0.11
ACHR -0.94%
$8.54
QBTS -2.48%
$27.62
WULF +3.33%
$16.11
SOUN -1.04%
$12.18
MIGI +45.65%
$6.70
JBLU +1.41%
$5.03
BDRX +86.97%
$7.61
KVUE +0.99%
$17.18
MRVL +3.32%
$91.85
TWOH
+16.66%
$0.00
WRBY +20.70%
$28.02
CHWY -1.23%
$34.41
YGMZ -19.73%
$0.05
CGC +1.78%
$1.15
LYFT -7.90%
$20.05
IONQ -5.05%
$51.69
SMCI -0.55%
$34.82
AMD -0.41%
$220.70
HBAN +1.20%
$17.19
SHOT -74.37%
$0.39
RR +1.38%
$4.40